Carregando...
Paving the Road Ahead for CD19 CAR T Cell Therapy
PURPOSE OF REVIEW: Modern immunotherapies, most notably in the form of anti-CD19 chimeric antigen receptor (CAR) T cells, have produced significant clinical responses in otherwise refractory pre-B cell acute lymphoblastic leukemia (ALL) patients. Several groups have simultaneously reported robust re...
Na minha lista:
| Publicado no: | Curr Opin Hematol |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718736/ https://ncbi.nlm.nih.gov/pubmed/26335422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0000000000000182 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|